CNSI Cambridge Neuroscience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CNSI Cambridge Neuroscience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: TheSlowLane who wrote (216)	8/6/1997 7:39:00 PM
From: TheSlowLane	of 675

More than doubled my position in CNSI today after talking to my PW broker. He is again upbeat and is venturing to cautiously speculate about the possibility of the Cerestat stroke trials resuming. Of course, it is still anyone's guess. He claims that they have re-examined the fundamentals and looked at things really hard in the harsh light of being down quite a bit, at this point, and still feel that the fundamentals are still there. He still contends that a good TBI trial could get the stock to 20 and if the stroke trials ever got back on track and were successful, 40 is possible. I got the feeling that they are thinking that patient anomaly was responsible for the trial suspension and that it may be resumed with labeling restrictions. We'll see...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next